Catalent (CTLT)
(Delayed Data from NYSE)
$60.59 USD
-0.12 (-0.20%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $60.58 -0.01 (-0.02%) 7:48 PM ET
1-Strong Buy of 5 1
C Value A Growth A Momentum A VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (89 out of 251)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.80 | 1.55 | 9.99 |
Current Quarter Estimate | 0.11 | 0.44 | 61.00 |
Year Ago Quarter Estimate | -0.10 | 0.11 | 54.84 |
Next Quarter Estimate | 0.23 | -1.66 | 63.00 |
Next Year Estimate | 1.88 | 13.59 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 412.00 | 19.40 | 15.67 |
Next Year | 46.88 | 16.40 | 11.34 |
Last 5 Years | -158.40 | 7.80 | 8.10 |
Next 5 Years | 30.10 | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 242.84 | -2.64 |
Price/Book (MRQ) | 3.05 | 1.51 |
Price/Cash Flow (MRFY) | 23.14 | 8.65 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -22.72% | -56.43% |
Return on Equity (TTM) | -0.56% | -58.58% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.